IthaID: 1044


Names and Sequences

Functionality: Globin gene causative mutation Pathogenicity: Pathogenic / Likely Pathogenic
Common Name: CD 74-76 (-GCCTGG) HGVS Name: HBB:c.224_229delGCCTGG
Hb Name: Hb Saint-Antoine Protein Info: β 74(E18) - 75(E19) Gly-Leu->0

Context nucleotide sequence:
AAGTGCTCGGTGCCTTTAGTGATG [-/GCCTGG] CTCACCTGGACAACCTCAAGGGCA (Strand: -)

Also known as:

Comments: The deleted segment Gly-Leu β 74–75 (E 18–19) is the end of helix E and close to a loose zone. Although it is in the vicinity of one of the 2,3-diphosphoglycerate binding sites, it has apparently only minor consequences for the functional properties of the molecule. Reported in literature as HBB:c.223_228delGGCCTG, which does not follow the HGVS Sequence Variant Nomeclature recommendations.

We follow the HGVS sequence variant nomenclature and IUPAC standards.

External Links

Phenotype

Hemoglobinopathy Group: Structural Haemoglobinopathy
Hemoglobinopathy Subgroup: β-chain variant
Allele Phenotype:N/A
Stability: Unstable
Oxygen Affinity: N/A
Associated Phenotypes: N/A

Location

Chromosome: 11
Locus: NG_000007.3
Locus Location: 70948
Size: 6 bp
Located at: β
Specific Location: Exon 2

Other details

Type of Mutation: Point-Mutation(Deletion)
Effect on Gene/Protein Function: Frameshift (Translation)
Ethnic Origin: Mediterranean
Molecular mechanism: N/A
Inheritance: Recessive
DNA Sequence Determined: No

In silico pathogenicity prediction

Publications / Origin

  1. Wajcman H, Labie D, Schapira G, Two new hemoglobin variants with deletion. Hemoglobin tours: Thr 8 7 (F 3 ) deleted and hemoglobin St Antoine: Gly-Leu 74-75 (E 18-19 deleted. Consequences for oxygen affinity and protein stability., Biochimica et biophysica acta, 295(2), 495-504, 1973
Created on 2010-06-16 16:13:16, Last reviewed on 2019-11-11 13:09:44 (Show full history)

Disclaimer: The information on this website is provided as an information resource only and must not to be used as a substitute for professional diagnosis and treatment. The ITHANET Portal and IthaGenes are not responsible or liable for any advice, course of treatment, diagnosis or any other information, services or products that an individual obtains through this website.